Synthetic Cannabinoids Are More Potent, More Dangerous, and Harder to Detect Than Natural Cannabis | Research

The takeaway

A review of synthetic cannabinoid designer drugs found they are more potent and longer-lasting than THC, linked to psychosis, mania, and suicidal ideation, and rapidly evolving to evade detection and regulation.

Anyone considering synthetic cannabinoid products or who wants to understand their risks.

Synthetic cannabinoids are full agonists (THC is partial), producing more potent and dangerous effects

What the researchers found

The review compared synthetic cannabinoids to natural cannabis across several dimensions. Synthetic cannabinoids have effects somewhat similar to natural cannabis but are substantially more potent and longer-lasting than THC, owing to their high affinity and full agonist activity at cannabinoid receptors (THC is only a partial agonist).

The psychiatric effects are more severe than natural cannabis: psychosis, mania, suicidal ideation, paranoid delusions, and dependence have all been linked to synthetic cannabinoid use. The potency difference means that doses in recreational products can produce effects that natural cannabis never would.

A key public health challenge is the rapid development of novel compounds: as authorities ban specific synthetic cannabinoids, manufacturers modify the chemical structure to create legal alternatives. New screening techniques are constantly needed to detect evolving compounds.

Why it matters

Synthetic cannabinoids represent one of the most dangerous developments in the recreational drug landscape. Unlike natural cannabis, which has a relatively large margin of safety, synthetic cannabinoids can cause life-threatening toxicity, severe psychiatric emergencies, and death. Public education about the fundamental difference between these products and natural cannabis is critical.

The numbers in context

Synthetic cannabinoids are full agonists at CB1 (THC is a partial agonist). Novel compounds are developed rapidly to evade regulation. Linked to psychosis, mania, suicidal ideation, and dependence.

How the study worked

Narrative review of published literature on the prevalence, epidemiology, bio-behavioral effects, and detection of synthetic cathinones and synthetic cannabinoids.

What this study cannot tell us

The review covers two distinct drug classes (synthetic cathinones and synthetic cannabinoids), making cannabis-specific conclusions less detailed. Much of the evidence comes from case reports and poison center data rather than controlled studies. The rapidly evolving nature of synthetic drugs means the specific compounds discussed may already be outdated.

How to read the evidence

Moderate evidence from a narrative review synthesizing available epidemiological and clinical data.

When this study was published

Published in 2017. The synthetic cannabinoid landscape continues to evolve rapidly.

The bigger picture

The synthetic cannabinoid epidemic illustrates a broader pattern in drug policy: prohibition of natural cannabis may inadvertently drive users toward more dangerous synthetic alternatives that are technically legal. Some public health advocates argue that access to regulated natural cannabis could reduce synthetic cannabinoid use and its associated harms.

Questions still open

Does legal natural cannabis access reduce synthetic cannabinoid use? Can detection technology keep pace with new compound development? Should public health messaging more aggressively differentiate natural cannabis from synthetic cannabinoids?

Common questions

Are synthetic cannabinoids ("Spice," "K2") the same as marijuana?

No. Despite being marketed as cannabis alternatives, synthetic cannabinoids are fundamentally different. They are full agonists at cannabinoid receptors (THC is a partial agonist), making them far more potent. They have been linked to severe psychiatric symptoms, organ damage, and deaths that natural cannabis does not typically cause.

Why are synthetic cannabinoids so dangerous?

Three reasons: they are much more potent than THC at cannabinoid receptors, their compositions are unknown and variable between batches, and they often contain non-cannabinoid chemicals with their own toxic effects. The combination creates unpredictable and sometimes life-threatening reactions.

Read the original research

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Frontiers in psychiatry, 8, 156

View on PubMed ↗Publisher’s paper ↗

Citation

Weinstein, Aviv M; Rosca, Paola; Fattore, Liana; London, Edythe D. (2017). Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.. Frontiers in psychiatry, 8, 156. https://doi.org/10.3389/fpsyt.2017.00156